# Guardian Pharmacy (GRDN) — Analyst Forecast

GRDN · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/grdn/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 7 | 0 | 0 | 7 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $49.00 | $50.67 | $52.00 | 3 |

Last price $39.68 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 23, 2026 | Keybanc | Initiated Coverage | Overweight | $52.00 |
| Sep 21, 2026 | Truist Securities | Maintained | Buy | $51.00 |
| Aug 7, 2026 | Oppenheimer | Maintained | Outperform | $49.00 |
| Jun 17, 2026 | B of A Securities | Maintained | Buy | $47.00 |
| Jun 17, 2026 | Truist Securities | Maintained | Buy | $47.00 |
| May 7, 2026 | Oppenheimer | Maintained | Outperform | $43.00 |
| Apr 27, 2026 | B of A Securities | Initiated Coverage | Buy | $42.00 |
| Apr 13, 2026 | Truist Securities | Maintained | Buy | $43.00 |
| Mar 30, 2026 | Jefferies | Initiated Coverage | Buy | $44.00 |
| Mar 12, 2026 | Truist Securities | Maintained | Buy | $38.00 |
| Mar 12, 2026 | Oppenheimer | Maintained | Outperform | $38.00 |
| Jan 14, 2026 | Stephens & Co. | Maintained | Overweight | $36.00 |
| Nov 14, 2025 | Truist Securities | Maintained | Buy | $34.00 |
| Oct 10, 2025 | Oppenheimer | Initiated Coverage | Outperform | $30.00 |
| Sep 26, 2025 | Truist Securities | Maintained | Buy | $30.00 |
| May 19, 2025 | Truist Securities | Maintained | Buy | $28.00 |
| Apr 11, 2025 | Truist Securities | Maintained | Buy | $25.00 |
| Nov 15, 2024 | Truist Securities | Maintained | Buy | $24.00 |
| Oct 22, 2024 | Stephens & Co. | Initiated Coverage | Overweight | $21.00 |
| Oct 21, 2024 | Truist Securities | Initiated Coverage | Buy | $22.00 |

## Frequently Asked Questions

### What is the price target for GRDN stock?

The average 12-month analyst price target for Guardian Pharmacy (GRDN) is $50.67, with a high estimate of $52.00 and a low of $49.00, across 3 analysts.

### Is GRDN a buy, sell, or hold?

Analysts covering Guardian Pharmacy currently average a Buy rating: 7 buy, 0 hold and 0 sell, from 7 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for GRDN?

The average price target of $50.67 implies 27.69% upside from the last price of $39.68.

### What is the latest analyst rating on GRDN?

On Sep 23, 2026, Keybanc initiated coverage of Guardian Pharmacy at Overweight with a price target of $52.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).